2 November, 2016
3PM London/11AM New York
How to successfully set up and run Direct to Patient trials
Recruiting patients and retaining their participation in a clinical trial remain the biggest challenges faced by pharmaceutical companies when developing new medicines. For a patient, participation in a clinical trial can be stressful and burdensome, resulting in one in four patients dropping out of a clinical trial prior to completion. With sponsors facing tight-timelines, increased regulatory scrutiny and spiralling budgets the desire to address these challenges has never been more prominent.
Taking a patient-centric approach and making the individual rather than the site the focal point of the study is now a common theme in addressing the challenge. An increasingly common example of this philosophy in practice is the concept of Home Trial Support and Direct to Patient delivery. By relocating the clinical trial to the patient’s home through trained medical personnel and specialised logistics capabilities it minimizes the inconvenience to patients, increasing the possibility they consent to participate in a clinical trial and reduces the possibility they withdraw from the study prior to its completion.
In this, the third in a series of webinars focused on the benefits of taking a patient-centric approach to pharmaceutical development The Medical Research Network (MRN) and World Courier to discuss the practical aspects of Home Trial Support and Direct to Patient Deliveries. Stuart Redding Vice President of Global Business Development & Marketing at MRN and Dave Spillett Key Account Director at World Courier will share their experiences of setting up and implementing the home care model, taking into account varying international regulation, the criticality of patient confidentiality and risk mitigation.
Join us for the next World Courier and MRN webinar, where we explore how practical knowledge and experience are the keys to successfully improving patient experience and moving medicine forwards.
Key Learning Objectives